Clinical trial
A Phase II Trial of TPI 287 in Patients With Metastatic Prostate Cancer
NCT00479635 · Cortice Biosciences, Inc., Industry · Terminated
Key facts
| NCT number | NCT00479635 |
|---|---|
| Title | A Phase II Trial of TPI 287 in Patients With Metastatic Prostate Cancer |
| Official title | A Phase II Trial of TPI 287 in Patients With Metastatic Prostate Cancer Who Have Progressive Neoplastic Disease Following Treatment With One Prior Taxane Regimen |
| Lead sponsor | Cortice Biosciences, Inc., Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | TPI 287 |
| Enrollment | 26 |
| Start date | Jan 1, 2007 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | May 28, 2007 |
| Last update posted | Jan 22, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: